Esco Aster vs ProBio

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/escoaster/probio

Category	Esco Aster	ProBio
Listed site	both	both
Summary	Esco Aster is a vertically integrated CDMO and CRO delivering end-to-end contract solutions from process development and GMP manufacturing through clinical research, with specialized capabilities in vaccine production, cell therapy, plasmid DNA, extracellular vesicles, and GLP toxicology.	ProBio is a leading global CDMO subsidiary of GenScript Biotech Corporation, providing end-to-end services for biologics and cell & gene therapy (CGT) from drug discovery through commercialization.
Services	Translational Research Clinical Trial Services GLP Toxicology Preclinical In Vitro Studies Preclinical In Vivo Studies	Analytical Method Development & Validation ICH Stability Studies In Vitro Pharmacology Protein Engineering Bioanalysis Flow Cytometry Services Immunogenicity Assays (ADA / NAb)
Modalities	Biologics (Other) Cell Therapy Gene Therapy Vaccine	Biologics (Monoclonal Antibodies) Biologics (Other) mRNA Cell Therapy Gene Therapy Vaccine AAV / Viral Vector Platform
Indications	Neurology Infectious Disease Respiratory Dermatology	Infectious Disease
Locations	Data not yet provided.	United States, United States Netherlands, Netherlands South Korea, South Korea Hong Kong, Hong Kong, China Shanghai, Shanghai, China Nanjing, Nanjing, China
Certifications	cGMP · Identifier: cGMP-compliant GLP · Identifier: GLP Toxicology	FDA · Identifier: US Food and Drug Administration EMA · Identifier: European Medicines Agency NMPA · Identifier: National Medical Products Administration
Reviews	Review summary appears after site-level review signal gate opens.	Review summary appears after site-level review signal gate opens.